XML 18 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Capital Surplus
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance at Dec. 31, 2021 $ 355.6 $ 3.9 $ 941.0 $ (537.2) $ (52.1)
Beginning balance (shares) at Dec. 31, 2021   393.8      
Increase/(Decrease) in Stockholders' Equity [Roll Forward]          
Net income 293.3     293.3  
Stock-based compensation 10.7   10.7    
Common stock dividends and dividend equivalents declared (92.6)     (92.6)  
Repurchase and retirement of common shares (159.0) $ (0.1)   (158.9)  
Repurchase and retirement of common shares (shares)   (8.6)      
Shares issued under stock-based compensation plans 8.9 $ 0.1 8.8    
Shares issued under stock-based compensation plans (shares)   1.9      
Other comprehensive income/(loss) (Note 9) (64.1)       (64.1)
Ending balance at Mar. 31, 2022 352.8 $ 3.9 960.5 (495.4) (116.2)
Ending balance (shares) at Mar. 31, 2022   387.1      
Beginning balance at Dec. 31, 2022 $ 477.8 $ 3.7 995.9 (353.9) (167.9)
Beginning balance (shares) at Dec. 31, 2022 373.5 373.5      
Increase/(Decrease) in Stockholders' Equity [Roll Forward]          
Net income $ 151.8     151.8  
Stock-based compensation 8.0   8.0    
Common stock dividends and dividend equivalents declared (88.6)     (88.6)  
Repurchase and retirement of common shares (6.2) $ (0.1)   (6.1)  
Repurchase and retirement of common shares (shares)   (0.5)      
Shares issued under stock-based compensation plans 0.3 $ 0.1 0.2    
Shares issued under stock-based compensation plans (shares)   1.4      
Other comprehensive income/(loss) (Note 9) 9.7       9.7
Ending balance at Mar. 31, 2023 $ 552.8 $ 3.7 $ 1,004.1 $ (296.8) $ (158.2)
Ending balance (shares) at Mar. 31, 2023 374.4 374.4